Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Topotecan in Relapsed AML
NCT00003255Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 1999
- Primary completion
- Dec 2006
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of topotecan, carboplatin in acute myeloid leukemia (AML), sponsored by Cancer and Leukemia Group B. Started Nov 1999; status: completed.
02
Drugs
topotecancarboplatin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00003255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003255.